When the Valine at position 600 of the BRAF protein is replaced by a Glutamate, a BRAF V600E mutation occurs, leading to a significant increase in BRAF kinase activity, which activates the MAPK signaling pathway and thus transforms melanocytes into MM cells [60,61]. The gene discussed is BRAF; the disease is Miyoshi myopathy.